Position in MRNA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,282,837
+$553,504 QoQ
Shares Held
32,598
-4.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#211
of 777 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 10%
Shared 90%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $13,833,173 across 13 Biotechnology names. MRNA ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
25,423 | $2,881,951 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
50,719 | $2,786,501 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
32,598 | $2,282,837 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,741 | $1,858,266 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,371 | $1,478,413 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
15,682 | $1,227,430 | |
| 7 | CADL |
Candel Therapeutics, Inc.
|
52,778 | $543,613 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,485 | $307,543 |
All Filings in MRNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,282,837 | 32,598 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $1,729,333 | 34,042 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $242,260 | 8,215 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $212,012 | 8,208 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $226,458 | 8,208 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $232,271 | 8,193 | Shares | Other | 2025-05-20 | |
| 2024-09-30 | $462,931 | 6,927 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $244,862 | 2,062 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,902,309 | 17,852 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,518,104 | 15,265 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $782,938 | 7,580 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $271,431 | 2,234 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,135,448 | 26,927 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,630,009 | 31,344 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,236,107 | 18,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $711,678 | 4,982 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $946,051 | 5,492 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,311,552 | 5,164 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,336,869 | 6,072 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,798,066 | 7,652 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $685,392 | 5,234 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $638,416 | 6,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $411,552 | 5,817 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $503,663 | 7,844 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||